' ' . õ µ, 30 . 55~80 67 . 7~8ð , 3 . 30 30 30 3 . , 30 3.4mmHg . 30 3 1.7mmHg 5.1mmHg . 30 '' 6.6mmHg . , . . , . , µ . , ª . º , 24ð (127.6mmHg) (132.9mmHg) 5.3mmHg . . , 1ð ª . ü .
. . . . . , . 3 0.1% . SNP . 0.1% 60 . . . , . . , . . , , , , , , , . . NK T . . . . , . . . . . ·
19 (19) 19 , (Long COVID) . 4 . , , , · , (Brain fog) . (NIH) , 19 . 19 9 . 24 73 . , 19 (BBB) . BBB . . BBB , . . . 19 , , , . BBB . NIH 19 . . . . (Brain) 5 .
, " , " " " [= ] 7 23 . (EUSA Pharma) 13 . , . 6,500~7,700 , 1650 . -6 . , . 27.5 . 2~5 27% . 5 35% , . , . . , , , , , , , , . , , 2~3 . . , , , . . 2018 1 , 2018 2 . . . . . . 201… [+61 chars]
3 , , . .. 10 1 .?, , . , . ?. . 11~13%, . . . ?. , 10 . . . . . . . ?1 7%, 5 50% . . . . , .?. ., () , . () .?7~80% . 4mm . CT . , CT X- 3~4 . .?, 5mm . 5~15mm , '' . , ' ' . 1~2 .15~20mm ' ' . , . … [+54 chars]
. 10 146 . 14 . (AIDS·) (HIV· ) . 1981 1983 HIV . HIV . . () . . “ ” “ 50~70% ” . . . 30 . . 146 . 88 58 10 . 5.4g . 3g . . 2.98 . 3.46 . “ ” “ ” . ‘’ 6 .
[ ] () . '', '',' ', ' ' . . , . , . . '', '', '' 3 . '', '', '', '', ' . . . . PM 2.5 , . . '', '', '' . , . (AGE, Advanced glycation end product) 2 . . 2 , 2 , AGE . AGE . AGE . . , . , , . … [+81 chars]
( ) 19 . [= ] 19 . ( ) 19 . (NYU) 13() . , . 20 . . 2020 NYU 19 2 . NYU (SLE) 163 . 19 125(77%) 3 ( ) . 6 163 44 19 . 2 . 44 42 . 44 22%, 42%. . . . SLE , 3 . (https://www.thelancet.com/jo… [+111 chars]
. , ." " " ' (Fitzpatric skin type)' " . 1~6 . 3~4 . , . . . , . 15 . , . . . . 25% .
. 5 () . CRISPR Y Y Y . Y Y Y (pirfenidone) Y . Y DNA Y Y Kenneth Walsh . UNIVERSITY OF VIRGINIA HEALTH SYSTEM.
. . King’s College London NIHR King’s Clinical Research Facility Peter Goadsby “ .” . “ .” 40 . “ 1985 .” . , . . ? Heads Up Katy Munro ‘ ’ . . ‘ ’ ‘ ’ . . .” . Munro “ 25% . . . . , . [The… [+933 chars]
. , ." " " ' (Fitzpatric skin type)' " . 1~6 . 3~4 . , . . . , . 15 . , . . . . 25% .
